Abstract:Abstract Abstract 1466 Background: Histone acetyltransferases and histone deacetylases (HDAC) regulate gene expression through acetylation-deacetylation of histones. HDACs are the target of a family of compounds known as HDAC inhibitors, which have been shown to suppress pro-inflammatory cytokines and reduce acute graft-versus-host disease (GVHD) while preserving the graft-versus-leukemia (GVL) effect after allogeneic bone marrow transplantation (BMT) in mice. However, the role of individual HDAC members in the development of GVHD is not clear. Recently, HDAC11, the newest member of the HDAC family has emerged as an important transcriptional regulator of inflammatory responses in antigen-presenting cells (APCs)1. Here, we evaluated the role of HDAC11 on APCs and T cells in the allogeneic BMT setting in mice with genetic disruption of HDAC11. Method: Proliferation of wild-type (WT) and HDAC11 knock-out (KO) T cells in response to allogeneic antigens was compared by [H3] thymidine incorporation assay. Using the same method, we also tested the antigen presentation ability of WT and HDAC11 KO APCs. For in vivo studies, we used a clinical relevant mouse model of BMT: C57BL/6 (B6) ® BALB/c. To evaluate the role of HDAC11 in the function of T cells and APCs, WT and KO mice on B6 background were used as donors and recipients, respectively. Recipient survival was monitored daily and GVHD symptom was evaluated at least twice a week. HDAC11 KO mice were supplied by Merck and Co., Inc. Results: In vitro, HDAC11 KO T cells proliferated stronger than WT T cells under the stimulation of allogeneic APCs. Recipients of HDAC11 KO T cells lost significantly more body weight (p < 0.05), and died significantly sooner than those of WT T cells (p < 0.01). The pathologic score of KO recipients was higher than that of WT recipients in each of GVHD target organs including lung, liver, small intestine and colon. Mechanistically, we found that there were significantly more total and IFNγ-producing donor T cells in the recipients of KO cells than those of WT cells (p < 0.05). Collectively, HDAC11 KO T cells have higher activity in response to alloantigens in vitro and induced more severe GVHD in vivo compared to WT T cells. In contrast, KO and WT APCs had a similar ability to stimulate allogeneic T cells in vitro, and no significant difference in GVHD development was observed in WT or KO recipients after allogeneic BMT. Conclusion: HDAC11 negatively regulates T-cell function, but has no significant effect on APC function. This finding provides a rationale to promote T-cell immunity or tolerance by inhibiting or enhancing HDAC11, respectively. 1 Villagra et al. Nature Immunology, 10:92-100, 2009. Disclosures: No relevant conflicts of interest to declare.

HDAC11 Regulates Type I Interferon Signaling Through Defatty-Acylation of SHMT2.

T Cells Lacking Hdac11 Have Increased Effector Functions And Mediate Enhanced Alloreactivity In A Murine Model

Histone deacetylase 11 is an epigenetic regulator of cytotoxic T-lymphocyte effector function and memory formation (P1404)

HDAC11 Suppresses the Thermogenic Program of Adipose Tissue Via BRD2

Biological Function and Small Molecule Inhibitors of Histone Deacetylase 11

HDAC11, an Emerging Therapeutic Target for Metabolic Disorders

Degradation of HDAC10 by autophagy promotes IRF3-mediated antiviral innate immune responses

HDAC11 Regulates Expression of C/EBPβ and Immunosuppressive Molecules in Myeloid-Derived Suppressor Cells.

Histone Deacetylase Isoforms Regulate Innate Immune Responses by Deacetylating Mitogen-Activated Protein Kinase Phosphatase-1.

Hdac11 Inhibits T-Cell Response To Alloantigens And Reduces Gvhd In Mice

Histone Deacetylase 11 (HDAC11) is a Regulatory Checkpoint of T-Cell Function: Implications for T-Cell Adoptive Immunotherapy

Identification of A Discrete Subpopulation of T-Cells Over-Expressing Hdac11 with A Th17 Phenotype

HDAC11: A novel target for improved cancer therapy

Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function

Proteomic Identification and Functional Characterization of MYH9, Hsc70, and DNAJA1 As Novel Substrates of HDAC6 Deacetylase Activity

Host HDAC4 Regulates the Antiviral Response by Inhibiting the Phosphorylation of IRF3

Inhibition of Histone Deacetylase Activity Suppresses IFN-γ Induction of Tripartite Motif 22 Via CHIP-mediated Proteasomal Degradation of IRF-1.

HDAC11 deficiency resists obesity by converting adipose-derived stem cells into brown adipocyte-like cells

A Pan-Cancer Analysis Identifies HDAC11 As an Immunological and Prognostic Biomarker

Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases

A Novel Role for Histone Deacetylase 6 in the Regulation of the Tolerogenic STAT3/IL-10 Pathway in APCs.